{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:03:09Z","timestamp":1789268589130,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2024,6,1]]},"DOI":"10.1038\/s41416-024-02650-6","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T18:03:28Z","timestamp":1710439408000},"page":"1670-1678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Functional proteomics of colon cancer Consensus Molecular Subtypes"],"prefix":"10.1038","volume":"130","author":[{"given":"Jaime","family":"Feliu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"G\u00e1mez-Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mart\u00ednez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"P\u00e9rez-Wert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Matamala-Luengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vi\u00f1al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"L\u00f3pez- Vacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Dittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Rodr\u00edguez-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Custodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan \u00c1ngel","family":"Fresno Vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-3474","authenticated-orcid":false,"given":"Luc\u00eda","family":"Trilla-Fuertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2650_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2650_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:1291\u2013305.","journal-title":"Ann Oncol"},{"key":"2650_CR3","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.3390\/cancers14235891","volume":"14","author":"D Vi\u00f1al","year":"2022","unstructured":"Vi\u00f1al D, Martinez-Recio S, Martinez-Perez D, Ruiz-Gutierrez I, Jimenez-Bou D, Pe\u00f1a-Lopez J, et al. Clinical score to predict recurrence in patients with stage II and stage III colon cancer. Cancers (Basel). 2022;14:5891.","journal-title":"Cancers (Basel)"},{"key":"2650_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.20.02553","volume":"39","author":"MR Weiser","year":"2021","unstructured":"Weiser MR, Hsu M, Bauer PS, Chapman WC, Gonz\u00e1lez IA, Chatterjee D, et al. Clinical calculator based on molecular and clinicopathologic characteristics predicts recurrence following resection of stage I-III colon cancer. J Clin Oncol. 2021;39:911\u20139.","journal-title":"J Clin Oncol"},{"key":"2650_CR5","first-page":"146","volume":"1","author":"JL Marshall","year":"2007","unstructured":"Marshall JL, Haller DG, de Gramont A, Hochster HS, Lenz HJ, Ajani JA, et al. Adjuvant therapy for stage II and III colon cancer: Consensus Report of the International Society of Gastrointestinal Oncology. Gastrointest Cancer Res. 2007;1:146\u201354.","journal-title":"Gastrointest Cancer Res"},{"key":"2650_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.critrevonc.2016.11.007","volume":"109","author":"N Rodriguez-Salas","year":"2017","unstructured":"Rodriguez-Salas N, Dominguez G, Barderas R, Mendiola M, Garc\u00eda-Alb\u00e9niz X, Maurel J, et al. Clinical relevance of colorectal cancer molecular subtypes. Crit Rev Oncol Hematol. 2017;109:9\u201319.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2650_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1200\/JCO.2008.19.5362","volume":"27","author":"D Sargent","year":"2009","unstructured":"Sargent D, Sobrero A, Grothey A, O\u2019Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27:872\u20137.","journal-title":"J Clin Oncol"},{"key":"2650_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"2650_CR9","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.5306\/wjco.v12.i11.1000","volume":"12","author":"G Valenzuela","year":"2021","unstructured":"Valenzuela G, Canepa J, Simonetti C, Solo de Zald\u00edvar L, Marcelain K, Gonz\u00e1lez-Montero J. Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach. World J Clin Oncol. 2021;12:1000\u20138.","journal-title":"World J Clin Oncol"},{"key":"2650_CR10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cancers15041104","volume":"15","author":"E L\u00f3pez-Camacho","year":"2023","unstructured":"L\u00f3pez-Camacho E, Prado-V\u00e1zquez G, Mart\u00ednez-P\u00e9rez D, Ferrer-G\u00f3mez M, Llorente-Armijo S, L\u00f3pez-Vacas R, et al. A novel molecular analysis approach in colorectal cancer suggests new treatment opportunities. Cancers (Basel). 2023;15:1104.","journal-title":"Cancers (Basel)"},{"key":"2650_CR11","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073\u201387.e3.","journal-title":"Gastroenterology"},{"key":"2650_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18:1182\u201391.","journal-title":"Lancet Oncol"},{"key":"2650_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36:773\u20139.","journal-title":"J Clin Oncol"},{"key":"2650_CR14","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl J Med. 2020;383:2207\u201318.","journal-title":"N. Engl J Med"},{"key":"2650_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1672-0229(07)60018-7","volume":"5","author":"WC Cho","year":"2007","unstructured":"Cho WC. Proteomics technologies and challenges. Genomics Proteom Bioinforma. 2007;5:77\u201385.","journal-title":"Genomics Proteom Bioinforma"},{"key":"2650_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513:382\u20137.","journal-title":"Nature"},{"key":"2650_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar S, Huang C, Wang X, Petyuk VA, Savage SR, Wen B, et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 2019;177:1035\u201349.e19.","journal-title":"Cell"},{"key":"2650_CR18","doi-asserted-by":"publisher","first-page":"951","DOI":"10.15252\/msb.20177701","volume":"13","author":"M Frejno","year":"2017","unstructured":"Frejno M, Zenezini Chiozzi R, Wilhelm M, Koch H, Zheng R, Klaeger S, et al. Pharmacoproteomic characterisation of human colon and rectal cancer. Mol Syst Biol. 2017;13:951.","journal-title":"Mol Syst Biol"},{"key":"2650_CR19","doi-asserted-by":"publisher","first-page":"O111.016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet LC, Navarro P, Tate S, R\u00f6st H, Selevsek N, Reiter L, et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteom. 2012;11:O111.016717.","journal-title":"Mol Cell Proteom"},{"key":"2650_CR20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1074\/mcp.RA118.001288","volume":"18","author":"R Bruderer","year":"2019","unstructured":"Bruderer R, Muntel J, M\u00fcller S, Bernhardt OM, Gandhi T, Cominetti O, et al. Analysis of 1508 plasma samples by capillary-flow data-independent acquisition profiles proteomics of weight loss and maintenance. Mol Cell Proteom. 2019;18:1242\u201354.","journal-title":"Mol Cell Proteom"},{"key":"2650_CR21","doi-asserted-by":"publisher","first-page":"e2200011","DOI":"10.1002\/pmic.202200011","volume":"23","author":"T Guo","year":"2023","unstructured":"Guo T, Aebersold R. Recent advances of data-independent acquisition mass spectrometry-based proteomics. Proteomics. 2023;23:e2200011.","journal-title":"Proteomics"},{"key":"2650_CR22","doi-asserted-by":"publisher","first-page":"1750202","DOI":"10.1080\/20013078.2020.1750202","volume":"9","author":"X Zheng","year":"2020","unstructured":"Zheng X, Xu K, Zhou B, Chen T, Huang Y, Li Q, et al. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry. J Extracell Vesicles. 2020;9:1750202.","journal-title":"J Extracell Vesicles"},{"key":"2650_CR23","doi-asserted-by":"publisher","first-page":"687229","DOI":"10.3389\/fmolb.2021.687229","volume":"8","author":"J Rao","year":"2021","unstructured":"Rao J, Wan X, Tou F, He Q, Xiong A, Chen X, et al. Molecular characterization of advanced colorectal cancer using serum proteomics and metabolomics. Front Mol Biosci. 2021;8:687229.","journal-title":"Front Mol Biosci"},{"key":"2650_CR24","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1021\/acs.jproteome.0c00693","volume":"20","author":"P Steffen","year":"2021","unstructured":"Steffen P, Li J, Chandra J, Ahadi MS, Gill AJ, Engel AF, et al. Molecular features of lymph node metastasis in T1\/2 colorectal cancer from formalin-fixed paraffin-embedded archival specimens. J Proteome Res. 2021;20:1304\u201312.","journal-title":"J Proteome Res"},{"key":"2650_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/prca.201200048","volume":"7","author":"A G\u00e1mez-Pozo","year":"2013","unstructured":"G\u00e1mez-Pozo A, Ferrer NI, Ciruelos E, L\u00f3pez-Vacas R, Mart\u00ednez FG, Espinosa E, et al. Shotgun proteomics of archival triple-negative breast cancer samples. Proteom Clin Appl. 2013;7:283\u201391.","journal-title":"Proteom Clin Appl"},{"key":"2650_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340.","journal-title":"Nat Methods"},{"key":"2650_CR27","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1158\/0008-5472.CAN-14-1937","volume":"75","author":"A G\u00e1mez-Pozo","year":"2015","unstructured":"G\u00e1mez-Pozo A, Berges-Soria J, Arevalillo JM, Nanni P, L\u00f3pez-Vacas R, Navarro H, et al. Combined label-free quantitative proteomics and microRNA expression analysis of breast cancer unravel molecular differences with clinical implications. Cancer Res. 2015;75:2243\u201353.","journal-title":"Cancer Res"},{"key":"2650_CR28","doi-asserted-by":"crossref","unstructured":"Lauritzen S. Graphical models. Oxford, UK.: Oxford University Press;1996.","DOI":"10.1093\/oso\/9780198522195.001.0001"},{"key":"2650_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1109\/TIT.1968.1054142","volume":"14","author":"C Chow","year":"1968","unstructured":"Chow C, Liu C. Approximating discrete probability distributions with dependence trees. IEEE Trans Inf Theor. 1968;14:462\u20137.","journal-title":"IEEE Trans Inf Theor"},{"key":"2650_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1090\/S0002-9939-1956-0078686-7","volume":"7","author":"J Kruskal","year":"1956","unstructured":"Kruskal J. On the shortest spanning subtree of a graph and the traveling salesman problem. Proc Am Math Soc. 1956;7:48\u201350.","journal-title":"Proc Am Math Soc"},{"key":"2650_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v037.i01","volume":"37","author":"G Abreu","year":"2010","unstructured":"Abreu G, Edwards D, Labouriau R. High-dimensional graphical model search with the gRapHD R Package. J Stat Softw. 2010;37:1\u201318.","journal-title":"J Stat Softw"},{"key":"2650_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"2650_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10493-w","volume":"7","author":"A G\u00e1mez-Pozo","year":"2017","unstructured":"G\u00e1mez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, L\u00f3pez-Vacas R, D\u00edaz-Almir\u00f3n M, et al. Functional proteomics outlines the complexity of breast cancer molecular subtypes. Sci Rep. 2017;7:10100.","journal-title":"Sci Rep"},{"key":"2650_CR34","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2650_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2144\/03342mt01","volume":"34","author":"AI Saeed","year":"2003","unstructured":"Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34:374\u20138.","journal-title":"Biotechniques"},{"key":"2650_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"2650_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603\u20137.","journal-title":"Nature"},{"key":"2650_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0691-y","volume":"16","author":"KCG Berg","year":"2017","unstructured":"Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, et al. Multi-omics of 34 colorectal cancer cell lines\u2014a resource for biomedical studies. Mol Cancer. 2017;16:116.","journal-title":"Mol Cancer"},{"key":"2650_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03232-z","volume":"11","author":"M Fichtner","year":"2020","unstructured":"Fichtner M, Bozkurt E, Salvucci M, McCann C, McAllister KA, Halang L, et al. Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant. Cell Death Dis. 2020;11:1020.","journal-title":"Cell Death Dis"},{"key":"2650_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41418-017-0011-5","volume":"25","author":"JF Linnekamp","year":"2018","unstructured":"Linnekamp JF, Hooff SRV, Prasetyanti PR, Kandimalla R, Buikhuisen JY, Fessler E, et al. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models. Cell Death Differ. 2018;25:616\u201333.","journal-title":"Cell Death Differ"},{"key":"2650_CR41","doi-asserted-by":"publisher","first-page":"e201900517","DOI":"10.26508\/lsa.201900517","volume":"2","author":"J Ronen","year":"2019","unstructured":"Ronen J, Hayat S, Akalin A. Evaluation of colorectal cancer subtypes and cell lines using deep learning. Life Sci Alliance. 2019;2:e201900517.","journal-title":"Life Sci Alliance"},{"key":"2650_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41421-023-00605-4","volume":"9","author":"DM Borr\u00e0s","year":"2023","unstructured":"Borr\u00e0s DM, Verbandt S, Ausserhofer M, Sturm G, Lim J, Verge GA, et al. Single cell dynamics of tumor specificity vs bystander activity in CD8. Cell Discov. 2023;9:114.","journal-title":"Cell Discov"},{"key":"2650_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0586-6","volume":"10","author":"VL Hale","year":"2018","unstructured":"Hale VL, Jeraldo P, Chen J, Mundy M, Yao J, Priya S, et al. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers. Genome Med. 2018;10:78.","journal-title":"Genome Med"},{"key":"2650_CR44","doi-asserted-by":"publisher","first-page":"e10874","DOI":"10.15252\/msb.202110874","volume":"18","author":"K Imkeller","year":"2022","unstructured":"Imkeller K, Ambrosi G, Klemm N, Claveras Cabezudo A, Henkel L, Huber W, et al. Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels. Mol Syst Biol. 2022;18:e10874.","journal-title":"Mol Syst Biol"},{"key":"2650_CR45","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.1096\/fj.201902899R","volume":"34","author":"SW Lee","year":"2020","unstructured":"Lee SW, Kim HK, Naidansuren P, Ham KA, Choi HS, Ahn HY, et al. Peroxidasin is essential for endothelial cell survival and growth signaling by sulfilimine crosslink-dependent matrix assembly. FASEB J. 2020;34:10228\u201341.","journal-title":"FASEB J"},{"key":"2650_CR46","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1016\/j.ejca.2014.07.017","volume":"50","author":"JR Infante","year":"2014","unstructured":"Infante JR, Weiss GJ, Jones S, Tibes R, Bauer TM, Bendell JC, et al. Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours. Eur J Cancer. 2014;50:2897\u2013904.","journal-title":"Eur J Cancer"},{"key":"2650_CR47","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.21037\/atm-20-1095","volume":"8","author":"Z Yu","year":"2020","unstructured":"Yu Z, Wang J, Cai X, Gao Z, Wang S, Gu Y. Analysis of pemetrexed-based chemotherapy in the treatment of advanced colorectal cancer. Ann Transl Med. 2020;8:1368.","journal-title":"Ann Transl Med"},{"key":"2650_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3892\/or.2016.5234","volume":"37","author":"H Onozawa","year":"2017","unstructured":"Onozawa H, Saito M, Saito K, Kanke Y, Watanabe Y, Hayase S, et al. Annexin A1 is involved in resistance to 5-FU in colon cancer cells. Oncol Rep. 2017;37:235\u201340.","journal-title":"Oncol Rep"},{"key":"2650_CR49","first-page":"403","volume":"10","author":"M Cheng","year":"2020","unstructured":"Cheng M, Jiang Y, Yang H, Zhao D, Li L, Liu X. FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway. Am J Cancer Res. 2020;10:403\u201323.","journal-title":"Am J Cancer Res"},{"key":"2650_CR50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm.3175","volume":"19","author":"A Sadanandam","year":"2013","unstructured":"Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013;19:619\u201325.","journal-title":"Nat Med"},{"key":"2650_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.5369","volume":"250","author":"MA Komor","year":"2020","unstructured":"Komor MA, Bosch LJ, Coup\u00e9 VM, Rausch C, Pham TV, Piersma SR, et al. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression. J Pathol. 2020;250:288\u201398.","journal-title":"J Pathol"},{"key":"2650_CR52","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1002\/jcp.30402","volume":"236","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhu G, Lin C, Lin P, Chen H, He R, et al. Vimentin affects colorectal cancer proliferation, invasion, and migration via regulated by activator protein 1. J Cell Physiol. 2021;236:7591\u2013604.","journal-title":"J Cell Physiol"},{"key":"2650_CR53","doi-asserted-by":"publisher","first-page":"682594","DOI":"10.3389\/fmolb.2021.682594","volume":"8","author":"Z Wang","year":"2021","unstructured":"Wang Z, Jia L, Sun Y, Li C, Zhang L, Wang X, et al. CORO1C is associated with poor prognosis and promotes metastasis through PI3K\/AKT pathway in colorectal cancer. Front Mol Biosci. 2021;8:682594.","journal-title":"Front Mol Biosci"},{"key":"2650_CR54","doi-asserted-by":"publisher","first-page":"113172","DOI":"10.1016\/j.celrep.2023.113172","volume":"42","author":"U Ghoshdastider","year":"2023","unstructured":"Ghoshdastider U, Sendoel A. Exploring the pan-cancer landscape of posttranscriptional regulation. Cell Rep. 2023;42:113172.","journal-title":"Cell Rep"},{"key":"2650_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep24799","volume":"6","author":"I Kosti","year":"2016","unstructured":"Kosti I, Jain N, Aran D, Butte AJ, Sirota M. Cross-tissue analysis of gene and protein expression in normal and cancer tissues. Sci Rep. 2016;6:24799.","journal-title":"Sci Rep"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02650-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02650-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02650-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:03:11Z","timestamp":1715598191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02650-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,6,1]]}},"alternative-id":["2650"],"URL":"https:\/\/doi.org\/10.1038\/s41416-024-02650-6","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The work described has been carried out in accordance with the Declaration of Helsinki. Approval for the study was obtained from the La Paz University Hospital Ethical Committee (PI-1019) and informed written consent was obtained for each participant in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}